- Home
- MSFT vs JNJ Comparison
MSFT vs JNJ Comparison
Compare MSFT & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MSFT | JNJ |
|---|---|---|
| Founded | 1975 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6T | 589.2B |
| IPO Year | 1986 | 1944 |
Fundamental Metrics
Financial Performance| Metric | MSFT | JNJ |
|---|---|---|
| Price | $400.46 | $243.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 34 | 17 |
| Target Price | ★ $603.27 | $227.29 |
| AVG Volume (30 Days) | ★ 45.5M | 9.2M |
| Earning Date | 01-28-2026 | 01-21-2026 |
| Dividend Yield | 0.91% | ★ 2.13% |
| EPS Growth | 28.77 | ★ 71.26 |
| EPS | ★ 15.98 | 11.03 |
| Revenue | ★ $305,453,000,000.00 | $94,193,000,000.00 |
| Revenue This Year | $18.78 | $6.63 |
| Revenue Next Year | $15.58 | $7.21 |
| P/E Ratio | $25.15 | ★ $22.17 |
| Revenue Growth | ★ 16.67 | 5.08 |
| 52 Week Low | $344.79 | $141.50 |
| 52 Week High | $555.45 | $246.35 |
Technical Indicators
Market Signals| Indicator | MSFT | JNJ |
|---|---|---|
| Relative Strength Index (RSI) | 33.20 | 83.07 |
| Support Level | $398.01 | $237.40 |
| Resistance Level | $423.68 | $246.35 |
| Average True Range (ATR) | 11.38 | 3.66 |
| MACD | -1.93 | 0.87 |
| Stochastic Oscillator | 9.47 | 90.12 |
Price Performance
Historical ComparisonAbout MSFT Microsoft Corporation
Microsoft develops and licenses consumer and enterprise software. It is known for its Windows operating systems and Office productivity suite. The company is organized into three equally sized broad segments: productivity and business processes (legacy Microsoft Office, cloud-based Office 365, Exchange, SharePoint, Skype, LinkedIn, Dynamics), intelligence cloud (infrastructure- and platform-as-a-service offerings Azure, Windows Server OS, SQL Server), and more personal computing (Windows Client, Xbox, Bing search, display advertising, and Surface laptops, tablets, and desktops).
About JNJ Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.